PortfoliosLab logoPortfoliosLab logo
MDGL vs. EOSE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

MDGL vs. EOSE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Madrigal Pharmaceuticals, Inc. (MDGL) and Eos Energy Enterprises Inc (EOSE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDGL achieves a -17.44% return, which is significantly higher than EOSE's -47.12% return.


MDGL

1D
1.37%
1M
-10.95%
YTD
-17.44%
6M
-15.87%
1Y
62.66%
3Y*
21.44%
5Y*
34.82%
10Y*
46.09%

EOSE

1D
-2.26%
1M
-22.95%
YTD
-47.12%
6M
-59.16%
1Y
50.37%
3Y*
23.72%
5Y*
-21.15%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDGL vs. EOSE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
MDGL
Madrigal Pharmaceuticals, Inc.
-17.44%88.72%33.36%-20.28%242.52%-23.77%-2.47%
EOSE
Eos Energy Enterprises Inc
-47.12%135.80%345.87%-26.35%-80.32%-63.92%112.65%

Correlation

The correlation between MDGL and EOSE is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (All Time)
Calculated using the full available price history since Jun 3, 2020

0.15

Fundamentals

Market Cap

MDGL:

$13.96B

EOSE:

$3.30B

EPS

MDGL:

-$12.87

EOSE:

-$1.45

PS Ratio

MDGL:

10.21

EOSE:

12.40

Total Revenue (TTM)

MDGL:

$1.13B

EOSE:

$160.71M

Gross Profit (TTM)

MDGL:

$1.05B

EOSE:

-$163.73M

EBITDA (TTM)

MDGL:

-$287.63M

EOSE:

-$858.77M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDGL vs. EOSE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDGL
MDGL Risk / Return Rank: 7878
Overall Rank
MDGL Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
MDGL Sortino Ratio Rank: 8080
Sortino Ratio Rank
MDGL Omega Ratio Rank: 7777
Omega Ratio Rank
MDGL Calmar Ratio Rank: 7777
Calmar Ratio Rank
MDGL Martin Ratio Rank: 7575
Martin Ratio Rank

EOSE
EOSE Risk / Return Rank: 6060
Overall Rank
EOSE Sharpe Ratio Rank: 5858
Sharpe Ratio Rank
EOSE Sortino Ratio Rank: 6666
Sortino Ratio Rank
EOSE Omega Ratio Rank: 6464
Omega Ratio Rank
EOSE Calmar Ratio Rank: 5757
Calmar Ratio Rank
EOSE Martin Ratio Rank: 5656
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDGL vs. EOSE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and Eos Energy Enterprises Inc (EOSE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


MDGLEOSEDifference
Sharpe ratioReturn per unit of total volatility

+0.95

Sortino ratioReturn per unit of downside risk

+0.78

Omega ratioGain probability vs. loss probability

1.26

1.17

+0.09

Calmar ratioReturn relative to maximum drawdown

2.11

0.60

+1.52

Martin ratioReturn relative to average drawdown

4.63

1.16

+3.48

MDGL vs. EOSE - Sharpe Ratio Comparison

The current MDGL Sharpe Ratio is 1.35, which is higher than the EOSE Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of MDGL and EOSE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

MDGL vs. EOSE - Drawdown Comparison

The maximum MDGL drawdown since its inception was -98.40%, roughly equal to the maximum EOSE drawdown of -97.88%. Use the drawdown chart below to compare losses from any high point for MDGL and EOSE.


Loading charts...

Drawdown Indicators


MDGLEOSEDifference

Max Drawdown

Largest peak-to-trough decline

-98.40%

-97.88%

-0.52%

Max Drawdown (1Y)

Largest decline over 1 year

-29.36%

-77.10%

+47.74%

Max Drawdown (3Y)

Largest decline over 3 years

-52.88%

-87.18%

+34.30%

Max Drawdown (5Y)

Largest decline over 5 years

-61.41%

-96.77%

+35.36%

Max Drawdown (10Y)

Largest decline over 10 years

-82.19%

Current Drawdown

Current decline from peak

-20.25%

-80.09%

+59.84%

Average Drawdown

Average peak-to-trough decline

-58.52%

-72.37%

+13.85%

Ulcer Index

Depth and duration of drawdowns from previous peaks

13.38%

39.66%

-26.28%

Volatility

MDGL vs. EOSE - Volatility Comparison

The current volatility for Madrigal Pharmaceuticals, Inc. (MDGL) is 13.71%, while Eos Energy Enterprises Inc (EOSE) has a volatility of 31.08%. This indicates that MDGL experiences smaller price fluctuations and is considered to be less risky than EOSE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDGLEOSEDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.71%

31.08%

-17.37%

Volatility (6M)

Calculated over the trailing 6-month period

31.76%

91.90%

-60.14%

Volatility (1Y)

Calculated over the trailing 1-year period

45.97%

115.13%

-69.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

133.37%

117.06%

+16.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

117.49%

112.92%

+4.57%

Dividends

MDGL vs. EOSE - Dividend Comparison

Neither MDGL nor EOSE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

MDGL vs. EOSE - Financials Comparison

This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and Eos Energy Enterprises Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M20222023202420252026
311.34M
56.96M
(MDGL) Total Revenue
(EOSE) Total Revenue
Values in USD except per share items

Frequently Asked Questions


MDGL and EOSE have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

EOSE has higher volatility (31.08%) compared to MDGL (13.71%). In terms of maximum drawdown, MDGL dropped -98.40% vs EOSE's -97.88%.

MDGL currently has the higher Sharpe Ratio (1.35 vs 0.40), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDGL and EOSE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer